InsiderClue
Insiders · Profile

CANAAN X L.P.

10% owner at IDEAYA Biosciences · 10% owner at NextCure · 10% owner at Protagonist Therapeutics. Filing since 16 Aug 2016. CIK 0001619859

IDYA IDEAYA Biosciences, Inc. 10% owner · 1 trade NXTC NextCure, Inc. 10% owner · 1 trade PTGX Protagonist Therapeutics, Inc 10% owner · 14 trades
Company
Date
Role
Action
Shares
Amount
Of holding
IDYA IDEAYA Biosciences, Inc.
28 May 2019
10% owner
Bought
400,000
$4.00M
17.7%
NXTC NextCure, Inc.
13 May 2019
10% owner
Bought
50,000
$750.00K
2.3%
PTGX Protagonist Therapeutics, Inc
17 May 2018
10% owner
Sold, plan not stated
38,968
$237.36K
1.8%
PTGX Protagonist Therapeutics, Inc
16 May 2018
10% owner
Sold, plan not stated
29,441
$190.07K
1.3%
PTGX Protagonist Therapeutics, Inc
15 May 2018
10% owner
Sold, plan not stated
57,715
$374.08K
2.6%
PTGX Protagonist Therapeutics, Inc
14 May 2018
10% owner
Sold, plan not stated
77,591
$494.22K
3.3%
PTGX Protagonist Therapeutics, Inc
23 Mar 2018
10% owner
Sold, plan not stated
59,950
$1.24M
2.5%
PTGX Protagonist Therapeutics, Inc
22 Mar 2018
10% owner
Sold, plan not stated
4,759
$98.13K
0.2%
PTGX Protagonist Therapeutics, Inc
21 Mar 2018
10% owner
Sold, plan not stated
17,699
$364.73K
0.7%
PTGX Protagonist Therapeutics, Inc
20 Mar 2018
10% owner
Sold, plan not stated
17,060
$351.54K
0.7%
PTGX Protagonist Therapeutics, Inc
19 Mar 2018
10% owner
Sold, plan not stated
13,439
$276.45K
0.6%
PTGX Protagonist Therapeutics, Inc
16 Mar 2018
10% owner
Sold, plan not stated
6,926
$142.06K
0.3%
PTGX Protagonist Therapeutics, Inc
15 Mar 2018
10% owner
Sold, plan not stated
11,751
$242.52K
0.5%
PTGX Protagonist Therapeutics, Inc
14 Mar 2018
10% owner
Sold, plan not stated
200
$4.15K
0.0%
PTGX Protagonist Therapeutics, Inc
13 Mar 2018
10% owner
Sold, plan not stated
1,204
$25.09K
0.0%
PTGX Protagonist Therapeutics, Inc
16 Aug 2016
Director
Bought
583,333
$7.00M
31.2%
16 decisions on file.